clinical trial · NCT07290400
Effect of Moderate Alcohol on Absorption and Onset of Hezkue Sildenafil Suspension
Aspargo Labs, Inc·phase2·not yet recruiting·n = 36
Erectile DysfunctionHezkue Sildenafil Oral SuspensionModerate Alcohol Intake
brief summary
This is a Phase 2, open-label, randomized crossover study assessing the effect of moderate alcohol intake on the absorption and onset of action of Hezkue® sildenafil oral suspension in adult subjects. Participants will receive Hezkue® under different alcohol intake conditions in randomized sequence. Pharmacokinetic sampling and onset assessments will be performed after each administration, and safety will be monitored throughout the study.
started
Apr 15, 2026
primary completion
Jun 15, 2026
completion
Jun 28, 2026
last updated
Dec 18, 2025
official title
Phase 2 Crossover Study Assessing the Effect of Moderate Alcohol Intake on the Absorption and Onset of Action of Hezkue® Sildenafil Oral Suspension
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol